Cargando…

Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria

BACKGROUND: The effects of enterolignans, e.g., enterodiol (END) and particularly its oxidation product, enterolactone (ENL), on prevention of hormone-dependent diseases, such as osteoporosis, cardiovascular diseases, hyperlipemia, breast cancer, colon cancer, prostate cancer and menopausal syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng-Zhi, Ma, Xiao-Qing, Yang, Dong-Hui, Guo, Zhi-Rong, Liu, Gui-Rong, Zhao, Ge-Xin, Tang, Jie, Zhang, Ya-Nan, Ma, Miao, Cai, Shao-Qing, Ku, Bao-Shan, Liu, Shu-Lin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865466/
https://www.ncbi.nlm.nih.gov/pubmed/20398397
http://dx.doi.org/10.1186/1471-2180-10-115
_version_ 1782180840758837248
author Wang, Cheng-Zhi
Ma, Xiao-Qing
Yang, Dong-Hui
Guo, Zhi-Rong
Liu, Gui-Rong
Zhao, Ge-Xin
Tang, Jie
Zhang, Ya-Nan
Ma, Miao
Cai, Shao-Qing
Ku, Bao-Shan
Liu, Shu-Lin
author_facet Wang, Cheng-Zhi
Ma, Xiao-Qing
Yang, Dong-Hui
Guo, Zhi-Rong
Liu, Gui-Rong
Zhao, Ge-Xin
Tang, Jie
Zhang, Ya-Nan
Ma, Miao
Cai, Shao-Qing
Ku, Bao-Shan
Liu, Shu-Lin
author_sort Wang, Cheng-Zhi
collection PubMed
description BACKGROUND: The effects of enterolignans, e.g., enterodiol (END) and particularly its oxidation product, enterolactone (ENL), on prevention of hormone-dependent diseases, such as osteoporosis, cardiovascular diseases, hyperlipemia, breast cancer, colon cancer, prostate cancer and menopausal syndrome, have attracted much attention. To date, the main way to obtain END and ENL is chemical synthesis, which is expensive and inevitably leads to environmental pollution. To explore a more economic and eco-friendly production method, we explored biotransformation of enterolignans from precursors contained in defatted flaxseeds by human intestinal bacteria. RESULTS: We cultured fecal specimens from healthy young adults in media containing defatted flaxseeds and detected END from the culture supernatant. Following selection through successive subcultures of the fecal microbiota with defatted flaxseeds as the only carbon source, we obtained a bacterial consortium, designated as END-49, which contained the smallest number of bacterial types still capable of metabolizing defatted flaxseeds to produce END. Based on analysis with pulsed field gel electrophoresis, END-49 was found to consist of five genomically distinct bacterial lineages, designated Group I-V, with Group I strains dominating the culture. None of the individual Group I-V strains produced END, demonstrating that the biotransformation of substrates in defatted flaxseeds into END is a joint work by different members of the END-49 bacterial consortium. Interestingly, Group I strains produced secoisolariciresinol, an important intermediate of END production; 16S rRNA analysis of one Group I strain established its close relatedness with Klebsiella. Genomic analysis is under way to identify all members in END-49 involved in the biotransformation and the actual pathway leading to END-production. CONCLUSION: Biotransformation is a very economic, efficient and environmentally friendly way of mass-producing enterodiol from defatted flaxseeds.
format Text
id pubmed-2865466
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28654662010-05-07 Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria Wang, Cheng-Zhi Ma, Xiao-Qing Yang, Dong-Hui Guo, Zhi-Rong Liu, Gui-Rong Zhao, Ge-Xin Tang, Jie Zhang, Ya-Nan Ma, Miao Cai, Shao-Qing Ku, Bao-Shan Liu, Shu-Lin BMC Microbiol Research article BACKGROUND: The effects of enterolignans, e.g., enterodiol (END) and particularly its oxidation product, enterolactone (ENL), on prevention of hormone-dependent diseases, such as osteoporosis, cardiovascular diseases, hyperlipemia, breast cancer, colon cancer, prostate cancer and menopausal syndrome, have attracted much attention. To date, the main way to obtain END and ENL is chemical synthesis, which is expensive and inevitably leads to environmental pollution. To explore a more economic and eco-friendly production method, we explored biotransformation of enterolignans from precursors contained in defatted flaxseeds by human intestinal bacteria. RESULTS: We cultured fecal specimens from healthy young adults in media containing defatted flaxseeds and detected END from the culture supernatant. Following selection through successive subcultures of the fecal microbiota with defatted flaxseeds as the only carbon source, we obtained a bacterial consortium, designated as END-49, which contained the smallest number of bacterial types still capable of metabolizing defatted flaxseeds to produce END. Based on analysis with pulsed field gel electrophoresis, END-49 was found to consist of five genomically distinct bacterial lineages, designated Group I-V, with Group I strains dominating the culture. None of the individual Group I-V strains produced END, demonstrating that the biotransformation of substrates in defatted flaxseeds into END is a joint work by different members of the END-49 bacterial consortium. Interestingly, Group I strains produced secoisolariciresinol, an important intermediate of END production; 16S rRNA analysis of one Group I strain established its close relatedness with Klebsiella. Genomic analysis is under way to identify all members in END-49 involved in the biotransformation and the actual pathway leading to END-production. CONCLUSION: Biotransformation is a very economic, efficient and environmentally friendly way of mass-producing enterodiol from defatted flaxseeds. BioMed Central 2010-04-16 /pmc/articles/PMC2865466/ /pubmed/20398397 http://dx.doi.org/10.1186/1471-2180-10-115 Text en Copyright ©2010 Wang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Wang, Cheng-Zhi
Ma, Xiao-Qing
Yang, Dong-Hui
Guo, Zhi-Rong
Liu, Gui-Rong
Zhao, Ge-Xin
Tang, Jie
Zhang, Ya-Nan
Ma, Miao
Cai, Shao-Qing
Ku, Bao-Shan
Liu, Shu-Lin
Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title_full Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title_fullStr Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title_full_unstemmed Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title_short Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
title_sort production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865466/
https://www.ncbi.nlm.nih.gov/pubmed/20398397
http://dx.doi.org/10.1186/1471-2180-10-115
work_keys_str_mv AT wangchengzhi productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT maxiaoqing productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT yangdonghui productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT guozhirong productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT liuguirong productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT zhaogexin productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT tangjie productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT zhangyanan productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT mamiao productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT caishaoqing productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT kubaoshan productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria
AT liushulin productionofenterodiolfromdefattedflaxseedsthroughbiotransformationbyhumanintestinalbacteria